Alpha 1 antitrypsin augmentation for alpha 1 antitrypsin deficiency associated lung disease
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of alpha 1 antitrypsin augmentation therapy on respiratory disease in people with alpha 1 antitrypsin deficiency.
Authors
- Nicola Robinson (ORCID: https://orcid.org/0000-0001-5256-4527)
- Amy Ward
- Iain Crossingham (ORCID: https://orcid.org/0000-0002-1797-8668)
- Patrick Glaister
- Chloe Bentham
Institutions
- East Lancashire Hospitals NHS Trust (GB)
Publication Details
- Journal
- Cochrane Database of Systematic Reviews
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1002/14651858.cd015930
- Citations
- 1
- Primary Topic
- Protease and Inhibitor Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.29